Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas F Gajewski

Showing results (131-140 of 236) with videos related to

Pageof 24
Sort By:
Cancer Immunology Research|May 20, 2016
Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder CancerRandy F Sweis, Stefani Spranger, Riyue Bao, et al.
Journal for Immunotherapy of Cancer|April 6, 2018
Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancerRandy F Sweis, Yuanyuan Zha, Lomax Pass, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Homeostatic proliferation plus regulatory T-cell depletion promotes potent rejection of B16 melanomaJustin Kline, Ian E Brown, Yuan-Yuan Zha, et al.
Science (New York, N.Y.)|January 6, 2018
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patientsVyara Matson, Jessica Fessler, Riyue Bao, et al.
The Journal of Experimental Medicine|September 21, 2011
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cellsMercedes B Fuertes, Aalok K Kacha, Justin Kline, et al.
Cancer Immunology Research|November 15, 2018
High-Throughput Stability Screening of Neoantigen/HLA Complexes Improves Immunogenicity PredictionsDylan T Blaha, Scott D Anderson, Daniel M Yoakum, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2002
Cutting edge: targeted ligation of CTLA-4 in vivo by membrane-bound anti-CTLA-4 antibody prevents rejection of allogeneic cellsKwang Woo Hwang, William B Sweatt, Ian E Brown, et al.
Journal of Translational Medicine|January 5, 2012
The immune score as a new possible approach for the classification of cancerJérôme Galon, Franck Pagès, Francesco M Marincola, et al.
Journal of Translational Medicine|May 17, 2011
Review of the 25th annual scientific meeting of the International Society for Biological Therapy of CancerJames M Balwit, Pawel Kalinski, Vernon K Sondak, et al.
Oncoimmunology|July 29, 2016
Unlocking tumor vascular barriers with CXCR3: Implications for cancer immunotherapyMaryann E Mikucki, Joseph J Skitzki, John G Frelinger, et al.
Pageof 24

Showing results (131-140 of 236) with videos related to

Sort By:
Pageof 24
Cancer Immunology Research|May 20, 2016
Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder CancerRandy F Sweis, Stefani Spranger, Riyue Bao, et al.
Journal for Immunotherapy of Cancer|April 6, 2018
Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancerRandy F Sweis, Yuanyuan Zha, Lomax Pass, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Homeostatic proliferation plus regulatory T-cell depletion promotes potent rejection of B16 melanomaJustin Kline, Ian E Brown, Yuan-Yuan Zha, et al.
Science (New York, N.Y.)|January 6, 2018
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patientsVyara Matson, Jessica Fessler, Riyue Bao, et al.
The Journal of Experimental Medicine|September 21, 2011
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cellsMercedes B Fuertes, Aalok K Kacha, Justin Kline, et al.
Cancer Immunology Research|November 15, 2018
High-Throughput Stability Screening of Neoantigen/HLA Complexes Improves Immunogenicity PredictionsDylan T Blaha, Scott D Anderson, Daniel M Yoakum, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2002
Cutting edge: targeted ligation of CTLA-4 in vivo by membrane-bound anti-CTLA-4 antibody prevents rejection of allogeneic cellsKwang Woo Hwang, William B Sweatt, Ian E Brown, et al.
Journal of Translational Medicine|January 5, 2012
The immune score as a new possible approach for the classification of cancerJérôme Galon, Franck Pagès, Francesco M Marincola, et al.
Journal of Translational Medicine|May 17, 2011
Review of the 25th annual scientific meeting of the International Society for Biological Therapy of CancerJames M Balwit, Pawel Kalinski, Vernon K Sondak, et al.
Oncoimmunology|July 29, 2016
Unlocking tumor vascular barriers with CXCR3: Implications for cancer immunotherapyMaryann E Mikucki, Joseph J Skitzki, John G Frelinger, et al.
Pageof 24